Navigation Links
Pharmaceuticals Wholesaling in Australia Industry Market Research Report Now Updated by IBISWorld

Melbourne, Australia (PRWEB) August 05, 2014

Operators in the Pharmaceuticals Wholesaling industry in Australia are an important interface between local and international pharmaceutical manufacturers and the nation's 5,300 community pharmacies. Pharmaceutical wholesalers are involved in the procurement, distribution and sale of a range of pharmaceutical and medicinal products. These products include prescription medicines, pharmacy-only medicines, over-the-counter (OTC) medicines and other healthcare products.

According to IBISWorld industry analyst Arna Richardson, “following relatively strong revenue growth in the early 2000s, growth rates began to falter in 2005-06.” This was in line with changes to the industry's operating environment and slower growth in the Pharmaceutical Benefits Scheme (PBS). The PBS is a government scheme for subsidising the cost of pharmaceuticals to the community. PBS reforms instituted over the five years through 2014-15 have presented the most fundamental changes to the scheme over its 60-year history. “Changes have included mandatory price cuts on many generic and off-patent drugs as part of the move towards mandatory price disclosure,” says Richardson. There has also been a change in the pricing mechanism (to weighted average disclosed prices) that determines wholesaler margins. The industry has also been influenced by changes to the Community Service Obligation (CSO). Negotiations for the terms of the next CSO for 2015 to 2020 are expected to commence later in 2014.

The industry exhibits a medium level of market share concentration. Major players include Sigma Pharmaceuticals Limited, Ebos Group Limited and Australian Pharmaceutical Industries Limited. In 2014-15, industry revenue is anticipated to fall by 3.8%, due to several factors. The industry is expected to contend with challenging conditions within the downstream retail pharmacy segment, patent expiries in view of the passing patent cliff and cuts to generic prices as the first round of simplified price disclosure cuts comes into effect on 1 October 2014. Revenue for 2014-15 is estimated at $11.4 billion, down from $13.3 billion in 2009-10. The Pharmaceuticals Wholesaling industry is expected to contract by an annualised 3.0% over the five-year period. These variables will continue to affect the industry in the next five years, particularly if other upstream pharmaceutical manufacturers follow Pfizer's 2011 example and implement exclusive distribution arrangements. In addition, the market environment will generate pressure for further change, as wholesalers move away from traditional distribution in favour of new business models with a stronger retail and professional services focus.

For more information, visit IBISWorld’s Pharmaceuticals Wholesaling report in Australia industry page.

Follow IBISWorld on Twitter:!/ibisworldau.

IBISWorld industry Report Key Topics

The industry comprises companies that wholesale human-use pharmaceutical products, including prescription drugs, over-the-counter medicines and complementary or alternative medicines. It also covers companies involved in the wholesale of veterinary drugs and medicines. The products are obtained from the relevant upstream manufacturer and distributed to hospitals, veterinarians and various retail outlets, including pharmacies and supermarkets.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
International Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalisation
Major Companies
Operating Conditions
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognised as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every Australian industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Melbourne, IBISWorld serves a range of business, professional service and government organisations through more than 10 locations worldwide. For more information, visit or call (03) 9655 3886.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. New UT Arlington research could improve pharmaceuticals testing
2. Actos Bladder Cancer Allegations Attorney Help: Resource4thePeople Comments on Progress of Federal Litigation Involving Cancer Claims Filed against Takeda Pharmaceuticals
3. Global Pharmaceuticals & Medicine Manufacturing Industry Market Research Report from IBISWorld has Been Updated
4. Database tracks toxic side effects of pharmaceuticals
5. Fem Med Formulas Announces an Exclusive License Agreement with NewBridge Pharmaceuticals
6. Actos Bladder Cancer Allegation Lawyer: Resource4thePeople Reports New Cases Involving Cancer Claims Filed against Takeda Pharmaceuticals
7. OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide
8. Biopharmaceuticals - A Global Market Overview
9. FDA Issues Letter to Sunovion Pharmaceuticals, Claims Patient Brochures Made by Company to Support Its Respiratory Drug Brovana Mislead, Parker Waichman LLP Notes
10. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013
11. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
Breaking Medicine Technology: